The London-based biotech beauty brand co-founded by Tendai Moyo and Ugo Agbai has closed a funding round co-led by the corporate venture arm of one of the world’s largest consumer goods companies. The deal brings Ruka’s total lifetime funding to $10 million and signals something larger: that the global hair extensions category is being taken seriously as a materials science and biotechnology opportunity, not just a beauty one.
Ruka Hair has closed a $4.5 million funding round co-led by Henkel Ventures and Freedom Trail Capital, bringing the brand’s total lifetime funding to $10 million since its founding in 2020. The round also included participation from Big Issue Invest, Backed VC, and a group of strategic angel investors, among them Olympic sprinting medallist Dina Asher-Smith, media entrepreneur Julie Adenuga, retail and M&A expert Sophia Dennis, supply chain specialist Knut Alicke, culture and branding expert Didier Morais, and Nigerian entrepreneur Nana Otedola. Euromonitor International
The headline figure is significant. The investor syndicate is more significant still.
Henkel Ventures is the corporate venture capital arm of Henkel, the German conglomerate behind Schwarzkopf and Got2b, two of the world’s most recognised haircare brands. Its participation in a $4.5 million round for a London-based biotech hair extensions startup signals a level of strategic interest from an established global beauty infrastructure company that goes beyond financial return. Henkel is not investing in Ruka because it needs the exposure. It is investing because it sees in Ruka’s technology a potential reshaping of a category that it knows intimately. Statista
The Founders
Ruka was founded in 2020 by Tendai Moyo and Ugo Agbai, positioning itself at the intersection of materials science and the textured hair market. Moyo, a UK-based Zimbabwean entrepreneur, has been explicit about the personal and commercial motivation behind the brand’s founding. She has written publicly that her dream is to create brands that target underserved consumers who look like her, describing hair as a category that has historically lacked the scientific seriousness and the consumer respect that it deserves. COSMOPROF
Raising capital for Ruka has not been straightforward. As Moyo told the Business of Beauty, the challenge is that Ruka sits across multiple sectors. Beauty investors understand consumer and retail distribution. Biotech investors understand material science. Very few understand both well enough to back a company that requires expertise in each simultaneously. The investor syndicate assembled for this round suggests that Moyo has found a path through that gap. Credence Research
The Technology
Understanding why this round has attracted the attention it has requires understanding what Synths 2 actually is, because it is not simply a new synthetic hair product.
Synths 2 is a patent-pending, lab-grown fibre made from collagen protein, produced in Japan, that looks, feels, and performs like real human hair. It is biodegradable, hypoallergenic, and made without plastic or carcinogens. It is designed to work across curls, coils, and kinks, and it is engineered to respond to heat and water similarly to natural hair. Euromonitor International
The conventional synthetic hair extensions market has been built on petroleum-based fibres, predominantly Kanekalon-type materials, that cause scalp irritation, carry chemical risks, and contribute significant plastic waste to the environment. It is a category worth billions of dollars globally that has operated for decades with almost no materials innovation. Consumers have long navigated inconsistent quality, poor texture matching, limited sustainability standards, and fragmented sourcing across the synthetic hair market. That environment created room for companies focused on category-specific product development and deeper specialisation around textured hair consumers. Statista
Ruka is building into that room with a technology that, if it scales as the brand’s investors believe it can, would not merely improve the extensions category but fundamentally replace the materials infrastructure on which it currently operates.
What Each Investor Brings
The strategic composition of this investor syndicate is worth examining beyond the headline names.
Freedom Trail Capital brings portfolio expertise from culturally driven consumer brands, having backed Issa Rae’s Sienna Naturals and Kevin Hart’s VitaHustle, giving Ruka access to a network of founders and operators who have navigated the specific challenges of building community-first beauty brands into retail-ready businesses. Henkel Ventures brings the technical and scientific infrastructure of a company that has spent decades in professional and consumer haircare at global scale. Big Issue Invest brings the impact capital lens, relevant for a brand whose sustainability and consumer safety commitments are central to its market positioning. Backed VC brings European seed-stage operational expertise. Statista
The angel investors bring something different again. Dina Asher-Smith is not simply a celebrity endorser. She is a Black British athlete with a public platform built around performance, body confidence, and cultural authenticity. Her investment signals the brand’s resonance with the kind of high-profile, values-aligned African diaspora figures whose advocacy carries genuine community credibility. Nana Otedola’s participation, explicitly confirmed by Moyo as an Africa-first backing, is commercially significant for a brand whose expansion trajectory is pointing toward the continent whose consumers the product is most designed to serve.
Where The Money Goes
The capital will be used to grow Ruka’s retail footprint, bolster production, and support its 2026 expansion into the US market, where the brand is expected to join a major retailer before the end of the year. Additional investment will go toward toxicology and safety testing, an area Moyo has been publicly vocal about as one the broader extensions category has historically neglected, as well as continued development of the shape memory platform that sits behind Synths 2’s heat and water responsiveness. Statista
The US retail entry is the commercial move that will be most closely watched. A major US retailer partnership would give Ruka the distribution infrastructure, the consumer validation, and the sales volume data that would support a significantly larger subsequent round.
What This Deal Signals For African Healthcare
The Africa dimension of this deal operates on two levels. The first is the founder level: Tendai Moyo is a UK-based Zimbabwean entrepreneur building a brand whose primary consumer is the Black and textured-hair community, the majority of whom live on the African continent and in the global diaspora. The second is the product level: Synths 2 is specifically engineered for the hair types that African consumers have been most poorly served by the conventional extensions market.
Nana Otedola’s decision to back the round as an explicit Africa-first investor is a signal worth reading carefully. It suggests that the most commercially sophisticated Nigerian investors are watching the global biotech beauty space and identifying companies whose technology has direct application to the African market, regardless of where those companies are currently headquartered.
The global textured hair extensions market, dominated for decades by imported synthetic fibre products manufactured in Asia for Western and African consumers alike, is a category that African entrepreneurs have long identified as a value capture opportunity. Ruka is approaching that opportunity from the biotechnology end rather than the brand end. If Synths 2 becomes the material standard for the category, the implications for how the global textured hair industry is structured extend well beyond a single brand’s retail expansion.
“Our community has always been at the centre of everything we do,” Moyo said following the close of the round. “People shouldn’t have to choose between what looks good, what feels safe, and what aligns with their values. We’re building something that finally delivers on all three.”
That is not a marketing line. It is a product brief for an entire category that has never delivered on all three simultaneously. The $4.5 million is the capital to prove it is possible.
